Debulking of Advanced Gastrointestinal Stromal Tumor With Peritoneal Carcinomatosis Refractory to Imatinib and Sunitinib: A Case Report

Gastrointestinal stromal tumors (GISTs) are non-epithelial that arise in the gastrointestinal tract. Pharmacological treatments for GIST tyrosine kinase inhibitors. For metastatic disease, debulking may be helpful reducing tumor burden, thus increasing effectiveness of Debate on whether resection would benefit patient is still present. Here a case 52-year-old African American male presenting with malignant peritoneal carcinomatosis refractory to imatinib and sunitinib. Since this had stage IV metastasis it was ultimately decided proceed therapeutic procedure. patient, procedure increased medication reduced mass effect symptoms, improving quality life. J Med Cases. 2021;12(2):45-48 doi: https://doi.org/10.14740/jmc3598